The company has, however, postponed US regulatory filing for the drug due to manufacturing constraints
These concerns are not theoretical
In consideration of the dual roles of GLP-1RAs in hypoglycemic effects and preventing CVD among T2DM patients, we reviewed the cardiovascular effects and molecular mechanisms of GLP-1RAs in CVOTs, animal models and cultured cells, and discuss how these findings transform pharmacotherapies for T2DM, and even expand the indication of this important category of anti-diabetic drugs to CVD patients without diabetes
Woodworth JC, Minton JE, Tokach MD, Nelssen JL, Goodband RD, Dritz SS, et al
If you want help deciding which path fits your health profile, take the free assessment quiz